Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Document › Details

Aragen Life Sciences Pvt. Ltd.. (6/29/21). "Press Release: Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim". Hyderabad.

Organisations Organisation Aragen Life Sciences Pvt. Ltd.
  Group Aragen (Group)
  Organisation 2 Boehringer Ingelheim (Group)
Products Product drug discovery
  Product 2 drug screening (service)
Person Person Kantipudi, Manni (Aragen 202106 CEO)
     


Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesize, profile, and then characterize a wide range of chemotypes against key targets of interest in swift optimization cycles. The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies. Biology screening of appropriate chemical moieties to drive decision making with speed and accuracy is also included in the partnership. Aragen will dedicate a sizeable portion of its campus in Hyderabad to support this alliance.

“We at Aragen believe that ‘In Every Molecule is the Possibility for Better Health’, and are excited about the opportunity to expand our partnership with Boehringer Ingelheim, a global leader in the discovery and development of novel medicines. It has been our privilege to collaborate with the scientists at Boehringer Ingelheim, and we thank them for their trust and confidence in the Aragen team. Together, we look forward to advancing Boehringer Ingelheim’s innovative approaches into successful clinical outcomes that can have the potential to ultimately benefit patients”, said Manni Kantipudi, CEO at Aragen.


About Aragen

Aragen Life Sciences Pvt Ltd (“Aragen”) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, we offer a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas. For more information, visit www.aragen.com


Media Contacts:

Aragen Life Sciences:
Sarat Patanaik, +91 95732 80064, sarat.patanaik@aragen.com

MediaMedic Communications Pvt.Ltd.:
Bhavna Pathak, +918830654608, info@mediamedichealth.com

   
Record changed: 2021-10-22

Advertisement

Picture EBD Group BIO-Europe 2021 Time to Register 650x200

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Plain Stupid Simple 650x80px




» top